▁Chron 9.296875
ic 0.548828125
▁pain 2.759765625
▁is 1.1630859375
▁still 6.71875
▁considered 3.98828125
▁to 1.927734375
▁be 0.032806396484375
▁an 2.6796875
▁extreme 7.26171875
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.15576171875
▁ 0.390380859375
8 3.47265625
% 2.19140625
▁of 0.122314453125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.319580078125
▁countries 0.91650390625
. 0.63525390625
▁The 2.115234375
▁introduction 7.74609375
▁of 0.0309906005859375
▁the 2.357421875
▁study 7.31640625
▁describes 7.28515625
▁the 0.5732421875
▁apparent 8.9140625
▁link 4.6796875
▁between 0.2406005859375
▁pain 2.71875
▁and 0.2958984375
▁dem 7.14453125
oral 3.390625
ization 0.12353515625
. 1.046875
▁Chron 4.515625
ic 0.0032253265380859375
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.6015625
▁accompanied 2.982421875
▁by 0.1500244140625
▁negative 4.1484375
▁emot 0.9111328125
ional 1.4072265625
▁experiences 2.984375
▁and 2.080078125
▁blocks 11.3046875
▁a 3.33984375
▁person 0.69140625
’ 0.876953125
s 0.0010728836059570312
▁ability 1.3876953125
▁to 0.037200927734375
▁receive 6.84375
▁joy 3.728515625
▁and 1.376953125
▁satisfaction 3.25390625
▁from 0.86767578125
▁life 0.79443359375
. 0.2281494140625
▁The 1.6455078125
▁research 2.693359375
▁investig 5.40625
ates 0.3876953125
▁the 0.38818359375
▁development 6.15234375
▁of 0.145751953125
▁de 3.83984375
pression 0.45849609375
▁and 1.357421875
▁anx 1.6201171875
iety 0.0010986328125
▁among 1.603515625
▁patients 1.4833984375
▁receiving 5.83203125
▁ph 5.4765625
arma 3.240234375
ce 0.01218414306640625
ut 6.61611557006836e-05
ical 0.006450653076171875
▁op 4.64453125
io 0.097900390625
ids 0.440185546875
▁and 2.4921875
▁medical 4.0546875
▁mar 1.744140625
iju 0.0010824203491210938
ana 4.839897155761719e-05
▁( 2.96484375
MM 1.2998046875
) 2.884765625
▁as 2.44140625
▁severe 9.984375
▁pain 0.7822265625
kill 2.658203125
ers 0.0005207061767578125
. 0.21630859375
▁It 3.2578125
▁comp 4.984375
ares 0.0084686279296875
▁the 0.58935546875
▁effic 4.296875
acy 0.0018758773803710938
▁of 0.2064208984375
▁pres 6.0859375
cri 1.9169921875
ptions 1.451171875
▁and 1.9296875
▁exam 4.49609375
ines 0.00980377197265625
▁the 0.473388671875
▁possibility 3.95703125
▁of 0.132080078125
▁post 8.203125
- 0.58740234375
tre 1.96875
at 0.001781463623046875
ment 0.004730224609375
▁de 1.6416015625
pression 0.08135986328125
. 1.384765625
▁There 5.67578125
▁is 1.146484375
▁currently 6.203125
▁a 1.1640625
▁severe 5.1171875
▁lack 1.6416015625
▁of 0.0124969482421875
▁information 2.236328125
▁about 1.205078125
▁the 0.58447265625
▁effects 3.2109375
▁of 0.06561279296875
▁op 3.447265625
i 3.546875
ates 0.01343536376953125
. 3.322265625
▁They 5.28515625
▁manage 8.640625
▁pain 3.125
▁successfully 5.80859375
, 0.9716796875
▁but 0.19140625
▁the 2.4609375
▁past 9.1484375
▁few 2.455078125
▁dec 1.341796875
ades 0.0011491775512695312
▁indicated 7.15625
▁the 1.765625
▁growing 3.634765625
▁concern 3.36328125
▁regarding 2.779296875
▁op 2.6796875
iate 1.224609375
▁ab 1.5693359375
use 0.0152587890625
▁in 3.92578125
▁forms 8.90625
▁of 0.251708984375
▁over 3.2265625
d 0.1046142578125
ose 0.30859375
▁and 0.6953125
▁add 0.70361328125
iction 0.01995849609375
. 0.12054443359375
▁Medical 3.61328125
▁mar 0.27880859375
iju 0.0009298324584960938
ana 0.00012814998626708984
▁might 5.8828125
▁be 0.70751953125
▁a 1.015625
▁sa 2.671875
fer 0.003955841064453125
▁alternative 0.853515625
. 2.05078125
▁However 3.328125
, 0.002086639404296875
▁the 1.736328125
▁legal 4.19140625
▁status 1.1181640625
▁and 2.916015625
▁novel 9.734375
ty 0.16748046875
▁of 0.1939697265625
▁this 2.16015625
▁drug 1.35546875
▁do 4.32421875
▁not 0.010284423828125
▁allow 0.59619140625
▁finding 6.8515625
▁a 2.41796875
▁large 2.4765625
▁number 0.7578125
▁of 0.00217437744140625
▁studies 1.31640625
▁on 1.7509765625
▁its 0.7890625
▁effect 2.451171875
iveness 0.1912841796875
. 0.62255859375
▁Specifically 9.125
, 0.031036376953125
▁it 2.625
▁concerns 5.44921875
▁the 0.83642578125
▁emot 6.35546875
ional 0.017303466796875
▁condition 4.62890625
▁of 0.23046875
▁patients 0.609375
▁experien 5.390625
cing 0.00017559528350830078
▁chron 0.8427734375
ic 0.00036406517028808594
▁pain 0.051300048828125
. 0.32373046875
▁This 3.05078125
▁research 1.8388671875
▁paper 4.0546875
▁a 2.107421875
ims 0.0011224746704101562
▁to 0.1141357421875
▁analyze 3.189453125
▁levels 10.1953125
▁of 0.0227508544921875
▁de 0.52294921875
pression 0.0258331298828125
▁and 0.1837158203125
▁anx 0.026153564453125
iety 0.00043129920959472656
▁among 0.72265625
▁people 2.62109375
▁receiving 2.232421875
▁ther 6.6015625
apy 0.11322021484375
▁by 4.60546875
▁comparing 8.078125
▁the 1.4775390625
▁effects 2.216796875
▁of 0.0250091552734375
▁ph 2.912109375
arma 0.02996826171875
ce 0.00296783447265625
ut 0.00014197826385498047
ical 0.0034008026123046875
▁op 0.11529541015625
io 0.43017578125
ids 0.0291748046875
▁and 0.2427978515625
▁MM 0.53125
. 0.29150390625
▁The 1.451171875
▁study 2.001953125
▁was 3.701171875
▁conducted 0.736328125
▁in 1.2841796875
▁the 1.36328125
▁form 2.634765625
▁of 0.002124786376953125
▁collection 11.5859375
▁and 0.7001953125
▁analysis 0.40625
▁of 0.00980377197265625
▁statistical 3.7421875
▁data 0.1253662109375
. 1.16015625
▁Part 5.58203125
icip 0.24462890625
ants 0.05572509765625
▁were 0.775390625
▁rec 3.76953125
ru 0.0009732246398925781
ited 0.0001239776611328125
▁for 4.26171875
▁six 6.96484375
▁months 0.372802734375
▁at 4.0625
▁two 2.619140625
▁major 3.96875
▁pain 2.626953125
▁relief 4.00390625
▁cent 0.81689453125
ers 0.032318115234375
▁in 0.64599609375
▁Israel 5.5078125
. 0.29541015625
▁The 1.1259765625
▁De 8.6484375
pression 0.02679443359375
▁Module 6.9375
▁of 0.7685546875
▁the 0.1610107421875
▁Pat 3.232421875
ient 0.011077880859375
▁Health 0.038421630859375
▁Question 0.020355224609375
naire 0.0169830322265625
▁and 2.2890625
▁the 0.2474365234375
▁General 1.158203125
ized 0.58740234375
▁An 0.00429534912109375
x 5.924701690673828e-05
iety 0.0003421306610107422
▁Dis 0.1798095703125
order 0.0187835693359375
▁Sc 1.193359375
ale 0.0030059814453125
▁were 0.329833984375
▁used 0.389404296875
▁to 0.69091796875
▁conduct 4.5625
▁the 0.72119140625
▁study 1.8662109375
. 0.08575439453125
▁To 5.328125
▁specifically 10.484375
▁evaluate 3.23046875
▁and 5.6171875
▁compare 0.5615234375
▁the 0.375732421875
▁prob 9.6171875
abilities 0.060272216796875
▁of 0.0732421875
▁de 0.8837890625
pression 0.041900634765625
▁or 4.55078125
▁anx 0.046112060546875
iety 0.0005545616149902344
▁among 1.4560546875
▁the 1.9140625
▁diverse 9.6328125
▁groups 0.7451171875
, 0.783203125
▁the 0.7734375
▁study 3.66015625
▁used 1.455078125
▁multiple 5.3671875
▁log 0.363037109375
istic 0.0237274169921875
▁regression 0.284912109375
▁analysis 1.30859375
▁and 2.94140625
▁chose 9.1171875
▁medical 6.296875
▁mar 0.08251953125
iju 0.0007753372192382812
ana 4.482269287109375e-05
▁as 0.47021484375
▁the 0.85791015625
▁control 2.919921875
▁group 0.68603515625
. 0.2138671875
▁This 3.720703125
▁type 4.60546875
▁of 0.00397491455078125
▁study 2.650390625
▁is 1.4404296875
▁the 3.732421875
▁most 1.5
▁reve 8.2265625
aling 0.000888824462890625
▁and 1.7314453125
▁inclus 7.01171875
ive 0.0010509490966796875
, 2.7109375
▁as 1.32421875
▁it 0.272705078125
▁contains 5.11328125
▁direct 6.51171875
▁responses 6.0
▁from 0.771484375
▁a 3.54296875
▁large 1.1171875
▁number 0.5048828125
▁of 0.002872467041015625
▁participants 1.125
. 0.62646484375
▁All 5.328125
▁tools 7.58203125
▁in 5.01171875
▁the 0.587890625
▁form 5.44921875
▁of 0.04669189453125
▁question 0.59619140625
na 0.01123046875
ires 0.0001920461654663086
▁and 1.853515625
▁scales 2.39453125
▁have 3.193359375
▁already 4.34765625
▁been 0.3359375
▁used 2.552734375
▁and 1.87109375
▁proved 2.443359375
▁their 1.494140625
▁effic 2.734375
acy 0.0026302337646484375
▁for 3.560546875
▁collect 3.978515625
ing 0.0034885406494140625
▁analyt 7.390625
ical 0.09246826171875
▁data 0.18896484375
. 0.358154296875
▁It 3.662109375
▁helps 4.54296875
▁to 0.4921875
▁system 6.6875
at 0.591796875
ize 0.001934051513671875
▁and 1.267578125
▁class 4.83984375
ify 0.0016431808471679688
▁distinct 8.0703125
▁kinds 6.19140625
▁of 0.0168609619140625
▁information 2.146484375
▁for 4.03515625
▁subsequent 4.90234375
▁un 8.4375
comp 4.22265625
licated 0.01824951171875
▁services 12.390625
. 0.57080078125
▁Thus 4.6953125
, 0.00641632080078125
▁research 4.9921875
ers 0.67138671875
▁can 1.478515625
▁compare 2.73828125
▁the 0.94287109375
▁effects 2.982421875
▁of 0.0950927734375
▁medic 3.798828125
ations 0.64892578125
▁on 1.533203125
▁patients 2.162109375
▁of 4.15625
▁diverse 3.06640625
▁age 1.9794921875
▁groups 2.017578125
, 0.8388671875
▁background 4.02734375
s 0.1405029296875
, 0.0379638671875
▁physical 5.71875
▁conditions 1.27734375
, 0.052886962890625
▁emot 6.44921875
ional 0.02618408203125
▁states 1.3427734375
, 0.05596923828125
▁and 0.397216796875
▁so 2.548828125
▁on 0.1968994140625
. 0.0546875
▁The 1.015625
▁analysis 3.58984375
▁of 0.98486328125
▁any 8.625
▁human 6.94921875
▁reaction 3.947265625
▁has 4.7734375
▁a 1.84765625
▁high 2.90625
▁potential 3.169921875
▁of 2.216796875
▁subject 4.296875
iveness 3.603515625
▁and 1.2958984375
▁bias 1.9658203125
, 1.6884765625
▁especially 2.8046875
▁regarding 3.75390625
▁people 4.90234375
▁in 3.78125
▁severe 2.478515625
▁pain 0.57763671875
▁and 2.47265625
▁un 5.7109375
stable 0.87158203125
▁emot 0.70166015625
ional 0.08660888671875
▁condition 2.328125
. 0.052764892578125
▁Perhaps 9.09375
▁some 5.5546875
▁patients 2.03515625
▁tend 4.5
▁to 0.0088043212890625
▁ex 1.986328125
agger 0.00897216796875
ate 0.0015630722045898438
▁their 0.98974609375
▁de 3.130859375
press 1.7412109375
ive 0.06402587890625
▁state 2.537109375
▁or 1.658203125
▁vice 5.6328125
▁vers 0.02239990234375
a 2.562999725341797e-05
, 1.099609375
▁de 7.27734375
- 2.65234375
emph 0.41796875
as 0.0023784637451171875
ize 0.0628662109375
▁serious 6.8203125
▁difficulties 5.5703125
. 0.73876953125
▁Because 6.421875
▁the 2.9765625
▁survey 5.05078125
▁responses 6.65625
▁were 1.419921875
▁thoroughly 8.4296875
▁anonymous 2.3984375
, 0.2529296875
▁the 1.34375
▁research 1.3671875
ers 0.374267578125
▁were 2.265625
▁unable 3.365234375
▁to 0.00165557861328125
▁carefully 8.046875
▁analyze 2.697265625
▁each 2.453125
▁patient 2.5078125
’ 0.54736328125
s 0.0012483596801757812
▁reaction 3.828125
▁and 1.49609375
▁compare 3.794921875
▁it 0.78515625
▁to 0.63427734375
▁the 0.9453125
▁actual 4.30078125
▁states 7.62890625
▁of 0.64697265625
▁condition 6.98046875
. 0.362060546875
▁More 6.07421875
▁accurate 3.34375
▁answers 4.87109375
▁could 1.91015625
▁be 0.71337890625
▁obtained 0.99853515625
▁by 1.5009765625
▁professional 5.91796875
▁psych 1.1533203125
olog 0.380615234375
ists 0.0012493133544921875
▁via 7.0546875
▁personal 2.611328125
▁communication 4.140625
▁and 2.095703125
▁behavior 6.1640625
al 0.251708984375
▁analysis 2.1484375
. 0.285888671875
▁However 1.490234375
, 0.0004506111145019531
▁this 1.5322265625
▁method 2.216796875
▁of 2.4921875
▁research 1.8955078125
▁is 1.0419921875
▁way 6.046875
▁more 1.005859375
▁resource 4.63671875
- 0.295166015625
int 1.416015625
ensive 0.023651123046875
▁and 0.436279296875
▁energy 10.6640625
- 0.07080078125
consum 0.371826171875
ing 0.0016489028930664062
. 0.6875
▁Part 6.40625
icip 0.43701171875
ants 0.1812744140625
▁were 1.5693359375
▁rec 2.046875
ru 0.0004067420959472656
ited 8.702278137207031e-06
▁for 1.91015625
▁six 0.323486328125
▁months 0.005962371826171875
▁at 0.337158203125
▁two 0.07305908203125
▁major 0.091064453125
▁pain 0.03228759765625
▁relief 0.0256500244140625
▁cent 0.01331329345703125
ers 0.0008115768432617188
▁in 0.044036865234375
▁Israel 0.01538848876953125
. 0.1627197265625
▁All 3.55078125
▁patients 1.873046875
▁experienced 4.58984375
▁chron 0.810546875
ic 0.00018596649169921875
▁pain 0.173583984375
▁for 2.49609375
▁at 0.6396484375
▁least 0.0017299652099609375
▁ 1.8544921875
3 1.525390625
▁months 0.25830078125
. 1.1943359375
▁The 1.3408203125
▁study 1.8447265625
▁included 1.60546875
▁ 0.61279296875
8 3.03515625
9 2.53515625
0 3.076171875
▁participants 1.625
, 1.572265625
▁of 2.6484375
▁which 0.46142578125
▁ 0.09478759765625
4 1.142578125
7 2.681640625
4 2.599609375
▁( 2.94921875
5 0.08441162109375
9 4.94140625
%) 0.79541015625
▁were 0.69921875
▁treated 3.240234375
▁sole 6.6015625
ly 7.855892181396484e-05
▁with 0.28515625
▁op 1.408203125
io 0.32080078125
ids 0.1390380859375
, 0.55810546875
▁ 0.71240234375
3 1.2314453125
2 2.23046875
9 2.47265625
▁( 0.03912353515625
4 2.46484375
1 1.1171875
%) 0.055938720703125
▁were 1.3935546875
▁treated 0.5146484375
▁with 0.42919921875
▁MM 0.61767578125
, 0.397705078125
▁and 0.09735107421875
▁ 0.2088623046875
7 1.9892578125
7 2.3828125
▁( 0.0904541015625
8 1.88671875
. 0.95556640625
6 2.349609375
%) 0.07257080078125
▁acquired 10.46875
▁both 0.64111328125
▁( 4.63671875
Fe 9.6015625
ing 1.4658203125
old 0.3544921875
▁et 1.0283203125
▁al 0.01934814453125
., 0.1456298828125
▁ 0.0115203857421875
2 0.0081787109375
0 0.00022971630096435547
1 0.33349609375
7 1.7216796875
). 0.04608154296875
▁The 0.9501953125
▁remaining 7.80859375
▁ten 6.78125
▁participants 1.3798828125
▁who 5.0390625
▁did 2.380859375
▁not 0.006259918212890625
▁receive 2.26171875
▁ph 3.83203125
arma 0.10186767578125
ce 0.00074005126953125
ut 2.5033950805664062e-06
ical 0.0024127960205078125
▁op 1.52734375
io 0.04180908203125
ids 0.02142333984375
▁and 2.392578125
▁medical 1.677734375
▁mar 0.035491943359375
iju 0.0002455711364746094
ana 4.661083221435547e-05
▁were 0.436767578125
▁with 6.734375
dra 0.054443359375
wn 4.100799560546875e-05
▁from 0.2454833984375
▁the 0.186767578125
▁analysis 2.06640625
▁in 4.92578125
▁the 1.3310546875
▁research 4.5703125
. 1.0927734375
▁Therefore 4.89453125
, 0.0130767822265625
▁it 3.79296875
▁is 1.2783203125
▁not 2.87890625
▁possible 0.7041015625
▁to 0.00785064697265625
▁compreh 5.84375
ens 0.129150390625
ively 0.0183258056640625
▁compare 1.2744140625
▁patients 5.21875
▁taking 3.71484375
▁medic 4.12109375
ations 0.55615234375
▁with 1.4189453125
▁those 1.0888671875
▁who 0.7744140625
▁do 1.3740234375
▁not 0.00437164306640625
. 0.61279296875
▁The 1.3857421875
▁study 1.828125
▁conducted 4.33203125
▁a 1.74609375
▁correlation 6.59765625
▁type 9.28125
▁of 0.2205810546875
▁research 0.8798828125
▁with 3.53125
▁variable 8.671875
▁measures 4.9765625
. 0.89990234375
▁It 1.658203125
▁evaluated 5.29296875
▁the 0.5341796875
▁inter 6.67578125
dep 2.33984375
end 0.00020396709442138672
ence 0.0086669921875
▁of 0.61279296875
▁various 3.43359375
▁factors 0.95654296875
▁that 2.837890625
▁affected 4.19140625
▁the 0.419921875
▁physical 6.3984375
▁and 0.284423828125
▁emot 0.478759765625
ional 0.00011229515075683594
▁condition 1.4013671875
▁of 0.046844482421875
▁patients 0.74658203125
▁experien 2.97265625
cing 1.6689300537109375e-06
▁chron 0.234619140625
ic 0.00019490718841552734
▁pain 0.0114593505859375
. 0.1256103515625
▁For 4.21875
▁example 1.1689453125
, 0.0014753341674804688
▁the 1.0703125
▁survey 5.515625
▁showed 3.958984375
▁that 0.4638671875
▁the 1.87890625
▁ratio 6.76953125
▁of 0.07305908203125
▁female 3.501953125
▁patients 0.90576171875
▁was 1.1982421875
▁remark 7.9453125
ably 0.00015485286712646484
▁higher 0.1761474609375
▁in 2.390625
▁the 0.4677734375
▁op 3.8515625
i 3.373046875
ates 0.0117340087890625
▁group 0.2049560546875
▁compared 2.451171875
▁to 0.042144775390625
▁the 0.55615234375
▁MM 0.166748046875
▁group 0.32568359375
. 0.46533203125
▁In 3.490234375
▁turn 4.23828125
, 0.0010776519775390625
▁people 4.90234375
▁on 4.7890625
▁op 3.205078125
i 0.6337890625
ates 0.003627777099609375
▁were 0.91552734375
▁more 1.4091796875
▁likely 0.28369140625
▁to 0.0258941650390625
▁report 2.8671875
▁major 5.953125
▁de 0.52685546875
press 0.7109375
ive 0.0023250579833984375
▁dis 0.88037109375
orders 1.6767578125
. 1.5595703125
▁The 1.6689453125
▁question 5.5703125
na 1.0400390625
ires 0.00017774105072021484
▁used 2.5703125
▁different 7.08984375
▁variable 8.046875
▁measures 0.35400390625
▁to 2.013671875
▁collect 2.439453125
▁information 1.5146484375
. 1.283203125
▁For 1.6123046875
▁example 0.29052734375
, 0.0014200210571289062
▁it 4.11328125
▁included 1.9765625
▁compreh 8.2421875
ensive 0.046356201171875
▁so 5.24609375
cio 0.0008578300476074219
- 0.2489013671875
dem 0.11578369140625
ographic 0.072265625
▁data 0.89453125
: 5.0703125
▁gender 2.00390625
, 0.042999267578125
▁age 0.2724609375
, 0.0386962890625
▁country 4.16015625
, 2.732421875
▁type 4.375
▁of 0.062103271484375
▁residence 3.982421875
▁( 2.607421875
urban 0.70654296875
/ 1.33203125
r 0.1534423828125
ural 0.0008373260498046875
), 0.17138671875
▁years 6.3203125
▁of 0.1697998046875
▁education 0.77392578125
, 0.0916748046875
▁and 1.4326171875
▁employ 2.583984375
ment 0.0016841888427734375
▁status 0.6328125
. 0.175537109375
▁Pat 4.5
ients 0.09112548828125
▁were 1.2197265625
▁also 0.90283203125
▁asked 0.47412109375
▁about 1.029296875
▁their 0.67724609375
▁medical 2.5
▁history 0.58984375
▁over 8.6640625
▁the 0.0633544921875
▁years 4.6796875
▁and 1.7119140625
▁the 1.423828125
▁current 2.92578125
▁presence 5.0
▁of 0.0740966796875
▁any 2.138671875
▁severe 3.630859375
▁dise 1.8427734375
ases 7.987022399902344e-05
▁such 4.39453125
▁as 0.0010471343994140625
▁heart 2.521484375
▁failure 1.66796875
, 0.29345703125
▁di 1.5625
ab 0.000640869140625
etes 0.0022563934326171875
, 0.07440185546875
▁ar 4.12109375
th 0.1339111328125
rit 0.0229034423828125
is 0.004058837890625
, 0.02703857421875
▁and 1.1630859375
▁so 0.74609375
▁on 0.054107666015625
. 0.053375244140625
▁The 1.4033203125
▁third 7.078125
▁measure 3.623046875
▁of 2.1640625
▁the 0.495849609375
▁question 1.8310546875
naire 0.338623046875
▁was 1.134765625
▁indicated 10.515625
▁by 1.16796875
▁information 6.60546875
▁on 2.015625
▁any 5.66015625
▁twelve 14.328125
- 0.23876953125
month 0.175537109375
▁and 4.93359375
▁lifetime 0.5927734375
▁drug 3.20703125
▁and 1.6630859375
▁alco 0.14306640625
hol 6.0677528381347656e-05
▁consumption 4.6640625
. 0.40966796875
▁In 3.19921875
▁addition 1.064453125
, 0.2666015625
▁the 0.9443359375
▁record 9.8828125
▁included 1.3857421875
▁a 2.693359375
▁pain 4.59765625
▁measurement 4.99609375
▁scale 0.8232421875
▁from 4.46875
▁ 0.556640625
0 0.299560546875
▁to 0.233154296875
▁ 0.00614166259765625
1 0.0689697265625
0 0.03369140625
▁to 3.37890625
▁evaluate 1.70703125
▁dis 6.10546875
com 0.1170654296875
fort 0.0022792816162109375
▁feelings 8.1953125
▁during 4.0859375
▁the 0.260498046875
▁last 1.0107421875
▁month 1.73046875
. 0.225341796875
▁Among 6.03125
▁all 2.484375
▁participants 2.373046875
▁in 3.974609375
▁the 0.183349609375
▁study 0.51123046875
, 0.034454345703125
▁ 0.76416015625
4 1.8583984375
2 2.376953125
. 1.1923828125
2 2.21875
% 0.062255859375
▁suffered 3.77734375
▁from 0.06573486328125
▁de 2.10546875
pression 0.294677734375
, 0.9462890625
▁and 1.26171875
▁ 0.11456298828125
3 1.4951171875
7 2.380859375
% 2.638671875
▁experienced 1.97265625
▁excess 6.78515625
ive 0.0254364013671875
▁anx 0.2342529296875
iety 0.0019779205322265625
. 0.430908203125
▁The 1.3935546875
▁pl 10.9296875
ur 0.8408203125
ality 0.0011444091796875
▁of 0.10302734375
▁de 2.416015625
press 1.248046875
ive 0.026824951171875
▁dis 2.33203125
orders 0.0701904296875
▁among 3.146484375
▁patients 1.0048828125
▁in 2.798828125
▁the 0.262451171875
▁op 0.490234375
i 0.388427734375
ates 0.0015125274658203125
, 9.3046875
▁medical 4.09765625
▁mar 0.0255126953125
iju 0.0005650520324707031
ana 2.4318695068359375e-05
, 0.233642578125
▁and 0.09173583984375
▁mixed 1.5703125
▁OP 11.359375
MM 4.14453125
▁groups 0.51708984375
▁number 9.3046875
ed 0.0190887451171875
▁ 0.158203125
5 1.69921875
7 2.66015625
. 0.46337890625
1 2.541015625
%, 0.1885986328125
▁ 0.0031490325927734375
2 1.8701171875
2 2.669921875
. 0.099609375
3 2.265625
%, 0.056243896484375
▁and 0.0523681640625
▁ 0.0018329620361328125
5 2.146484375
1 2.095703125
. 0.1561279296875
4 1.916015625
%, 0.1495361328125
▁respectively 0.0194091796875
. 0.280029296875
▁The 1.1748046875
▁pl 3.861328125
ur 0.00797271728515625
ality 5.161762237548828e-05
▁of 0.020721435546875
▁anx 0.423828125
iety 0.01666259765625
▁contained 11.0546875
▁ 0.2335205078125
4 1.1181640625
8 2.3671875
. 0.168701171875
4 2.193359375
% 2.021484375
▁among 2.525390625
▁OP 5.39453125
▁patients 5.92578125
, 0.278564453125
▁ 0.08612060546875
2 0.953125
1 2.513671875
. 0.10687255859375
5 2.11328125
% 0.0224761962890625
▁among 0.459228515625
▁MM 0.102294921875
▁patients 0.35498046875
, 0.019775390625
▁and 0.0140380859375
▁ 0.0246429443359375
3 1.357421875
8 1.9248046875
. 0.12744140625
7 2.201171875
% 0.01088714599609375
▁among 0.1861572265625
▁OP 1.9267578125
MM 0.12188720703125
▁participants 3.30859375
. 0.25341796875
▁Pat 4.6328125
ients 0.0193023681640625
▁who 1.9541015625
▁took 2.212890625
▁strong 9.5546875
▁op 0.65625
i 0.82275390625
ates 0.0028247833251953125
▁were 1.2099609375
▁t 10.1953125
ended 0.978515625
▁to 0.007312774658203125
▁place 9.734375
▁their 2.009765625
▁pain 0.9912109375
▁on 1.923828125
▁a 0.58935546875
▁scale 1.81640625
▁of 0.39208984375
▁ 0.1119384765625
9 2.484375
▁to 2.244140625
▁ 0.0109100341796875
1 0.00481414794921875
0 0.004779815673828125
▁( 2.6953125
Fe 1.701171875
ing 0.0020008087158203125
old 0.00031065940856933594
▁et 0.014129638671875
▁al 0.0012063980102539062
., 0.0088958740234375
▁ 0.0013151168823242188
2 0.00012981891632080078
0 2.014636993408203e-05
1 0.001983642578125
7 0.007381439208984375
). 0.01003265380859375
▁They 3.49609375
▁were 1.732421875
▁also 1.1435546875
▁an 9.640625
gu 4.75
ished 0.072021484375
▁em 5.98046875
otion 0.0006551742553710938
ally 0.0006427764892578125
▁and 1.169921875
▁react 7.45703125
ed 0.0233306884765625
▁rad 9.0859375
ically 0.0009655952453613281
▁neg 4.671875
atively 0.0012264251708984375
▁to 0.1903076171875
▁almost 5.32421875
▁all 1.5634765625
▁survey 3.7890625
▁questions 0.23876953125
. 0.322021484375
▁Pat 2.77734375
ients 0.005016326904296875
▁who 1.1572265625
▁took 1.673828125
▁only 4.5703125
▁MM 0.412353515625
▁or 2.990234375
▁mixed 2.412109375
▁medic 1.4912109375
ations 0.2095947265625
▁course 13.7734375
▁had 2.484375
▁a 1.3525390625
▁significantly 2.751953125
▁more 3.47265625
▁stable 2.53515625
▁emot 0.8037109375
ional 0.0008039474487304688
▁state 0.5546875
▁and 1.263671875
▁cop 6.71875
ed 0.027984619140625
▁with 0.354248046875
▁pain 0.8740234375
▁more 1.8564453125
▁manage 7.6875
able 1.044921875
. 0.254638671875
▁One 5.5234375
▁of 0.434326171875
▁the 0.00716400146484375
▁major 2.828125
▁limitations 2.826171875
▁is 3.3046875
▁the 0.56103515625
▁ins 4.64453125
u 0.06732177734375
fficient 0.095947265625
ly 3.53125
▁high 2.982421875
▁response 2.974609375
▁rate 0.1009521484375
, 2.732421875
▁ 4.41015625
5 1.68359375
7 2.64453125
% 2.306640625
▁instead 6.2578125
▁of 0.0028247833251953125
▁ 0.51806640625
7 1.7177734375
0 0.436279296875
% 1.4677734375
▁( 2.31640625
Fe 0.7490234375
ing 0.00157928466796875
old 0.00022983551025390625
▁et 0.01122283935546875
▁al 0.0006718635559082031
., 0.00611114501953125
▁ 0.0012731552124023438
2 8.475780487060547e-05
0 8.058547973632812e-05
1 0.0004329681396484375
7 0.00292205810546875
). 0.0115814208984375
▁It 1.9228515625
▁can 3.212890625
▁be 0.67529296875
▁explained 0.7060546875
▁by 0.0718994140625
▁the 0.424560546875
▁weak 6.94921875
▁focus 7.01171875
▁of 0.64404296875
▁respond 5.37890625
ents 0.1015625
▁who 3.61328125
▁have 3.779296875
▁overcome 8.359375
▁severe 2.0703125
▁pain 0.5126953125
▁sens 7.48828125
ations 0.18310546875
. 1.2841796875
▁It 2.841796875
▁is 0.7734375
▁not 2.48828125
▁clear 3.412109375
▁how 1.96484375
▁to 3.375
▁use 5.15625
▁these 2.978515625
▁statistics 4.0703125
, 2.974609375
▁as 0.71337890625
▁they 2.0078125
▁still 5.15234375
▁may 5.125
▁be 1.16015625
▁relevant 6.4921875
▁for 1.8095703125
▁the 1.88671875
▁overall 4.83203125
▁analysis 2.515625
. 0.79443359375
